Raw LLM Responses

Inspect the exact model output for any coded comment.

Comment
They have this already! It's called Quantitative Structure-Activity Relationships (QSAR) and it's modeling that can predict bioactivity, as well as a variety of other useful molecular descriptors, such as potential toxicity. The FDA already recommends the use of QSAR in mutagenicity studies for drug applications rather than lengthy in vitro studies. I'm actually writing a review article fo my masters on this exact topic! The use of AI in drug discovery and development. It's become really popular since the ICH M7 guidelines were released in 2016. I'm definitely going to incorporate the study linked to the article in my review. [Here's a related study exceedingly similar to the information referenced in the article, but specifically studying benzodiazapines.](https://pubmed.ncbi.nlm.nih.gov/34451817/)
reddit AI Bias 1637184651.0 ♥ 281
Coding Result
DimensionValue
Responsibilitynone
Reasoningunclear
Policyindustry_self
Emotionapproval
Coded at2026-04-25T08:33:43.502452
Raw LLM Response
[{"id":"rdc_mjlhsdh","responsibility":"none","reasoning":"unclear","policy":"unclear","emotion":"indifference"},{"id":"rdc_hl0mofx","responsibility":"ai_itself","reasoning":"consequentialist","policy":"unclear","emotion":"fear"},{"id":"rdc_hl0n3d6","responsibility":"none","reasoning":"unclear","policy":"unclear","emotion":"approval"},{"id":"rdc_hl1fcbm","responsibility":"none","reasoning":"unclear","policy":"industry_self","emotion":"approval"},{"id":"rdc_hl2dmcf","responsibility":"none","reasoning":"unclear","policy":"unclear","emotion":"mixed"}]